Inhibikase Therapeutics, Inc. Employee Directory

Pharmaceutical ManufacturingDelaware, United States11-50 Employees

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, Pulmonary Arterial Hypertension (“PAH”), that arise from aberrant signaling through the Abelson Tyrosine Kinase, and type III receptor tyrosine kinases including platelet derived growth factor receptors and c-KIT. Our lead product candidate is IKT-001, a prodrug of imatinib mesylate, for PAH which is an orphan indication. PAH is a progressive, life-threatening disease characterized by pulmonary vascular remodeling and elevated pulmonary vascular resistance that affects approximately 50,000 Americans. 

Inhibikase is headquartered in Wilmington, DE with additional offices in Boston, Massachusetts.

Find Inhibikase Therapeutics, Inc. employees' phone numbers or email addresses

Inhibikase Therapeutics, Inc. Global Highlights

Location
Employees

North America
31

Minus sign iconPlus sign icon
  • United States Of America
    30
  • Canada
    1

Europe
1

Minus sign iconPlus sign icon
  • Netherlands
    1

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

Inhibikase Therapeutics, Inc.'s Leadership

  • Stylized image of a person
    J. J. K.
    Chief Human Resources Officer
    Phone icon
  • Stylized image of a person
    J. F.
    Chief Financial Officer
    Phone icon
  • Stylized image of a person
    K. W.
    Vice President Finance
    Phone icon
  • Stylized image of a person
    C. M.
    Vice President Of Clinical Operations
    Phone icon
  • Stylized image of a person
    R. A.
    President
    Phone icon
  • Stylized image of a person
    S. S.
    Head Of Program Leadership
    Phone icon
  • Stylized image of a person
    A. M.
    Chairman
    Phone icon
  • Stylized image of a person
    J. A.
    Owner
    Phone icon

Inhibikase Therapeutics, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Business
  • Entrepreneurship
  • Human Resources
  • Accounting
  • Biotechnology
  • Other
  • Community & Social Services

Contact profiles from Inhibikase Therapeutics, Inc.

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    M. C.
    Vice-President
    Phone icon
    Oct 16, 2024
  • Stylized image of a person
    R. B.
    Director
    Phone icon
    CanadaQuebec
    Feb 11, 2026
  • Stylized image of a person
    L. B.
    Senior Director, Medical Affairs
    Phone icon
    Mar 20, 2026
  • Stylized image of a person
    A. L.
    Senior Director, Corporate Controller
    Phone icon
    United States
    Feb 11, 2026
  • Stylized image of a person
    E. M.
    Director Clinical Operations
    Phone icon
    United StatesNew Jersey
    Mar 19, 2026
  • Stylized image of a person
    C. H.
    Sr. Clinical Trial Manager
    Phone icon
    United StatesTexas
    Mar 02, 2026
  • Stylized image of a person
    R. S. O.
    Sr. Clinical Trial Manager
    Phone icon
    United StatesMassachusetts
    Mar 25, 2026
  • Stylized image of a person
    J. P.
    Senior Clinical Trial Associate
    Phone icon
    United StatesMassachusetts
    Mar 02, 2026
  • Stylized image of a person
    M. H.
    Project Management Consultant, Regulatory Affairs
    Phone icon
    United StatesMassachusetts
    Mar 27, 2026
  • Stylized image of a person
    K. A.
    Clinical Trial Assistant
    Phone icon
    United StatesOregon
    Mar 02, 2026

Frequently Asked Questions

What is Inhibikase Therapeutics, Inc. known for?

Minus sign iconPlus sign icon
Inhibikase Therapeutics, Inc. operates in the Pharmaceutical Manufacturing industry. The company's main headquarters is located in 1000 North West Street Suite 1200 Wilmington, Delaware United States. Explore Inhibikase Therapeutics, Inc.'s company overview page for more information.

What is Inhibikase Therapeutics, Inc.'s most common email format?

Minus sign iconPlus sign icon
Inhibikase Therapeutics, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Inhibikase Therapeutics, Inc. email formats with LeadIQ.

How many employees does Inhibikase Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
Inhibikase Therapeutics, Inc. has approximately 27 employees as of March 2026. These team members are located across 3 continents, including North AmericaEuropeSouth America.

Who are Inhibikase Therapeutics, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of March 2026, Inhibikase Therapeutics, Inc.'s key employees include:

  • Chief Human Resources Officer: J. J. K.
  • Chief Financial Officer: J. F.
  • Vice President Finance: K. W.
  • Vice President Of Clinical Operations: C. M.
  • President: R. A.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.